BAC vs BCRX Stock Comparison

BCRX currently leads BAC in this stock comparison, with AIQ scores of 59 vs 58. The clearest difference is value, while BAC has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 1 points
BAC
Financial Services
vs
BCRX
Healthcare
BAC
Bank of America Corporation
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services
BCRX
BioCryst Pharmaceuticals, Inc.
Leads
Price
$7.61
Day move
-0.91%
AIQ Score
59/100
Best edge
Value
Sector
Healthcare

What is the main difference between BAC and BCRX?

BCRX leads the current stock comparison as BioCryst Pharmaceuticals, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs BioCryst Pharmaceuticals, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

BCRX leads

BCRX leads by 1 AIQ points, primarily on Value and Momentum, having only recently taken the lead back from BAC.

Fragile: 2 of 6 evidence groups support BCRX, and the lead recently changed hands.

Evidence agreement: 2 of 6Comparison trend: Reversed
BAC

Bank of America Corporation

AIQ Score
58/100
AIQ Edge Score
6/10
BCRX

BioCryst Pharmaceuticals, Inc.

Leads
AIQ Score
59/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score currently favors BCRX over BAC, 59 versus 58 as of Nov 15, 2026. BCRX's advantage is driven primarily by stronger value and momentum, while BAC holds the stronger risk resilience profile. BCRX also shows the weaker technical structure relative to its 50-day moving average. 2 of 6 covered evidence groups favor BCRX today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. BCRX lead: Reversed — BAC led by 2 AIQ points 30 sessions ago; BCRX now leads by 1.

Compare Bank of America Corporation and BioCryst Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+24.0%
BCRX
-36.6%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $12,399 · BCRX $6,336

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and BCRX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
BCRX advantage
  • Risk Resilience83 vs 55
    BAC +28
  • Value68 vs 86
    BCRX +18
  • Momentum37 vs 42
    BCRX +5
  • Quality64 vs 64
    Even

2 of 6 evidence groups favor BCRX. BCRX’s edge is concentrated in value and momentum; BAC keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
BCRX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

BCRX's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and BCRX both carry a full feed there.

The central trade-off

BCRX (BioCryst Pharmaceuticals, Inc.): the stronger current systematic profile, led by value and momentum.

BAC (Bank of America Corporation): the counter-case, on risk resilience, fundamentals, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BCRX

BCRX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

BAC

BAC on combined revenue and EPS growth.

Value

BCRX

BCRX on the peer-relative Value factor, by 18 points.

Momentum

BCRX

BCRX on the Momentum factor, by 5 points.

Lower downside

BAC

BAC on Risk Resilience, by 28 points.

Analyst upside

BCRX

BCRX on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBACBCRXNote
Implied upside to target+24.1%+44.5%BCRX has more room
Target dispersion+25.3%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2511Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 6 covered evidence groups favor BCRX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven58 vs 59
FundamentalsBACrevenue growth -3.3% vs -17.4%; EPS growth -23.8% vs -51.6%; TTM ROE 2.3% vs -9.5%; gross margin 60.4% vs 25.3%; operating margin 22.4% vs -30.1%
ValuationBCRXValue 68 vs 86
TechnicalsBACPrice vs 50-day -5.6% vs -7.6%; vs 200-day -7% vs -13.5%
Risk ResilienceBACRisk Resilience 83 vs 55
Analyst expectationsBCRXTarget upside 24.1% vs 44.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and BCRX and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BCRX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

BCRX lead: Reversed — BAC led by 2 AIQ points 30 sessions ago; BCRX now leads by 1.

May 27BAC leads above the line · BCRX leads belowNov 13
Today
BCRX +1
58 vs 59
7 sessions ago
BCRX +4
58 vs 62
30 sessions ago
BAC +2
62 vs 60
90 sessions ago
Level
71 vs 71

The lead changed hands 6 times in this window, most recently on Oct 26 when BCRX moved ahead of BAC.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
BCRX

0 bullish / 2 bearish / 2 neutral

Only BCRX

  • ADX Trend Weakening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.55%)

Both carry 2 more signals that do not separate them: Death Cross Active, Downtrend Structure Active.

BAC is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

BCRXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.91%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BAC closes the Value gap — currently 18 points behind, the largest single contributor to BCRX's edge.
  2. 2BAC's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3BCRX starts generating bearish momentum or trend signals.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

BAC leads on balance
MetricBACBCRX
Revenue growth (YoY)-3.3%-17.4%
EPS growth (YoY)-23.8%-51.6%
Gross margin60.4%25.3%
Operating margin22.4%-30.1%
Return on equity (TTM)2.3%-9.5%
Debt to equity1.28-2.08

Performance

BAC leads 4 of 6 windows
MetricBACBCRX
1 week (5 sessions)3.2%-1%
1 month (20 sessions)-0.4%-2.3%
3 months (63 sessions)-20.1%-23.4%
6 months (126 sessions)2.5%-15.6%
Year to date-7.2%-2.4%
1 year (252 sessions)-5.7%6%

Technicals

BAC has the stronger structure
MetricBACBCRX
RSI (14)45.940.7
ADX (14)27.215.2
Price vs 50-day-5.6%-7.6%
Price vs 200-day-7%-13.5%
Volatility (1M, annualized)24.8%45.2%

Risk

BAC is the more resilient
MetricBACBCRX
Beta0.790.65
Sharpe ratio-0.220.36
Sortino ratio-0.290.56
Max drawdown-23.7%-32.2%
Current drawdown-21.3%-31.5%
Annualized volatility22.4%48.1%
Value at risk (95%)-2.6%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or BCRX?

On the Algovestiq AIQ Score, BCRX is the stronger of the two as of Nov 15, 2026, scoring 59 against BAC's 58. The edge comes from value and momentum. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or BCRX the better buy right now?

BCRX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor BCRX over BAC?

The composite weights Quality, Value, Momentum and Risk Resilience. BAC leads Risk Resilience by 28 points; BCRX leads Value by 18 points; BCRX leads Momentum by 5 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or BCRX?

Analyst price targets imply +24.1% upside for BAC and +44.5% for BCRX, so the Street currently favors BCRX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or BCRX?

BCRX is the better-valued of the two on the peer-relative Value factor. BCRX on the peer-relative Value factor, by 18 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or BCRX?

BAC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or BCRX?

BCRX on the Momentum factor, by 5 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or BCRX?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 28 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than BCRX?

BAC leads on the comparable margin measures — gross margin 60.4% vs 25.3%; operating margin 22.4% vs -30.1%; ttm roe 2.3% vs -9.5%.

Is BCRX's lead over BAC getting stronger or weaker?

BCRX lead: Reversed — BAC led by 2 AIQ points 30 sessions ago; BCRX now leads by 1. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 6 times in that window, most recently on 2026-10-26, when BCRX moved ahead of BAC.

What would change the BAC vs BCRX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Value gap — currently 18 points behind, the largest single contributor to BCRX's edge; BAC's Death Cross Active resolves — a bearish trend rule currently active against it; BCRX starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BAC and BCRX?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. BCRX: 0 bullish / 2 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On BCRX it is Death Cross Active (bearish, long horizon).

Compare BAC and BCRX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.